This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity

NCT06857617 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity and Overweight

Interventions

BIOLOGICAL: (Part C) MET097
BIOLOGICAL: (Part C) Placebo

Sponsor

Metsera, a wholly owned subsidiary of Pfizer